Apart from the pancreas, GLP-1R is also widely distributed in various tissues of the body including the lungs, kidneys, central nervous system, cardiovascular system, gastrointestinal tract, and skin and vagus nerves ( Glucagon like peptide-1 receptor agonists (GLP-1RAs) are emerging glucose control drugs, which are widely used in the treatment of T2MD in recent years
It is the major ingredient in both formulations
Nearly 7% of the overweight or obese patients taking semaglutide had NAION, compared to only 0.8% of patients who were not taking semaglutide
While many people with gallstones may not experience symptoms, its important to know that if a gallstone blocks your bile ducts, you might feel pain in your upper-right abdomen
MIC components are known for their fat-burning and liver-supporting properties, which, when paired with Semaglutide's appetite control, create a synergistic effect
Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding